Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
Study NCT ID:
NCT06567366
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-08-22
First Post:
2024-08-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-20
First Submit QC Date:
None
Study First Post Date:
2024-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-20
Last Update Post Date:
2024-08-22
Last Update Post Date Type:
ACTUAL